Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

Overview of attention for article published in New England Journal of Medicine, October 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 20 news outlets
blogs: 12 blogs
policy: 2 policy sources
twitter: 804 X users
facebook: 17 Facebook pages
wikipedia: 1 Wikipedia page

googleplus: 2 Google+ users
reddit: 5 Redditors
f1000: 1 research highlight platform
guideline: 2 clinical guideline sources
bluesky: 2 Bluesky users
podcasts: 3 podcasts

Readers on

mendeley: 981 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 1048 X posts from 804 X users, with an upper bound of 4,472,350 followers.

@NeurocritCareJ @SCCM 7/ Limited literature: ⚠️️MIND-USA (2018) (https://t.co/W14DfU7Ei9) did not show benefit to haldol or zyprexa in shortening ⏳of delirium ⚠️ AID-ICU (2022) (https://t.co/0o9rR6bNTe) did not change ☠️ ⚠️4D trial (2025) (https://…

出典：Girard TD, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med 2018. https://t.co/pHHd4fzycK

RT @ryoma_tanaka: 短期的にせん妄期間が変わらないのはこちらで発表されています。 MIND-USA https://t.co/vGg95kKAKO

短期的にせん妄期間が変わらないのはこちらで発表されています。 MIND-USA https://t.co/vGg95kKAKO

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1044 additional X posts.